FIRRM
FIGNL1-interacting regulator of recombination and mitosis
Also known as: C1orf112, FIRRM_HUMAN, FLJ10706
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NSG2
- Gene
- FIRRM
- Ensembl
- ENSG00000000460
- Chromosome
- 1
- Canonical length
- 853 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli
OverviewNCBI Gene
Enables protein kinase binding activity. Involved in several processes, including chromosome segregation; interstrand cross-link repair; and regulation of protein kinase activity. Located in several cellular components, including midbody; nuclear lumen; and spindle midzone. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
853 residues, UniProt reviewed canonical sequence.
>Q9NSG2|FIRRM
1 MFLPHMNHLT LEQTFFSQVL PKTVKLFDDM MYELTSQARG LSSQNLEIQT TLRNILQTMV
61 QLLGALTGCV QHICATQESI ILENIQSLPS SVLHIIKSTF VHCKNSESVY SGCLHLVSDL
121 LQALFKEAYS LQKQLMELLD MVCMDPLVDD NDDILNMVIV IHSLLDICSV ISSMDHAFHA
181 NTWKFIIKQS LKHQSIIKSQ LKHKDIITSL CEDILFSFHS CLQLAEQMTQ SDAQDNADYR
241 LFQKTLKLCR FFANSLLHYA KEFLPFLSDS CCTLHQLYLQ IHSKFPPSLY ATRISKAHQE
301 EIAGAFLVTL DPLISQLLTF QPFMQVVLDS KLDLPCELQF PQCLLLVVVM DKLPSQPKEV
361 QTLWCTDSQV SETTTRISLL KAVFYSFEQC SGELSLPVHL QGLKSKGKAE VAVTLYQHVC
421 VHLCTFITSF HPSLFAELDA ALLNAVLSAN MITSLLAMDA WCFLARYGTA ELCAHHVTIV
481 AHLIKSCPGE CYQLINLSIL LKRLFFFMAP PHQLEFIQKF SPKEAENLPL WQHISFQALP
541 PELREQTVHE VTTVGTAECR KWLSRSRTLG ELESLNTVLS ALLAVCNSAG EALDTGKQTA
601 IIEVVSQLWA FLNIKQVADQ PYVQQTFSLL LPLLGFFIQT LDPKLILQAV TLQTSLLKLE
661 LPDYVRLAML DFVSSLGKLF IPEAIQDRIL PNLSCMFALL LADRSWLLEQ HTLEAFTQFA
721 EGTNHEEIVP QCLSSEETKN KVVSFLEKTG FVDETEAAKV ERVKQEKGIF WEPFANVTVE
781 EAKRSSLQPY AKRARQEFPW EEEYRSALHT IAGALEATES LLQKGPAPAW LSMEMEALQE
841 RMDKLKRYIH TLGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FIRRM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 13 nTPM
- thymus: 11 nTPM
- testis: 9.6 nTPM
- bone marrow: 8.5 nTPM
- tonsil: 7.4 nTPM
- lymph node: 5.9 nTPM
Single-cell type
- cardiomyocytes: 89 nCPM
- thymocytes: 84 nCPM
- microglia: 78 nCPM
- early primary spermatocytes: 78 nCPM
- adipocytes: 63 nCPM
- hematopoietic stem cells: 55 nCPM
Immune cell
- non-classical monocyte: 2.4 nTPM
- basophil: 2.2 nTPM
- NK-cell: 2.2 nTPM
- intermediate monocyte: 2 nTPM
- memory B-cell: 1.4 nTPM
- naive B-cell: 1.4 nTPM
Brain region
- cerebellum: 4.7 nTPM
- white matter: 4.2 nTPM
- medulla oblongata: 3.3 nTPM
- basal ganglia: 3 nTPM
- thalamus: 3 nTPM
- cerebral cortex: 2.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.73
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chromosome segregation
- interstrand cross-link repair
- mitotic cell cycle
- regulation of protein kinase activity
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein of unknown function DUF4487
- Domain of unknown function (DUF4487)
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FIRRM in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FIRRM as an antibody target. Whether an autoantibody or antibody against FIRRM could matter depends on whether native FIRRM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FIRRM is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FIRRM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...